AstraZeneca's new thinking
Orest Lastow, project maanger at AstraZeneca, shows how Redundancy Based Development addresses and mitigates medical device development risks and delays.
Orest Lastow, project maanger at AstraZeneca, shows how Redundancy Based Development addresses and mitigates medical device development risks and delays.